The S&P 500’s bull market is set to turn three years old this weekend. Over that stretch, U.S. large caps have nearly doubled on a total return basis. Consumer Staples, however, has been largely left out of the upside move, butFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative ...

Industry Overview - The Zacks Tobacco industry is facing significant challenges, including declining cigarette sales due to shifting consumer preferences, inflationary pressures, and tightening regulations [1][4] - Rising health awareness and stricter restrictions on smoking are reducing demand for traditional tobacco products, negatively impacting overall industry performance [1][4] Key Trends - **Challenges in Cigarette Sales Volumes**: The industry is experiencing a decline in cigarette sales driven by inflation and changing consumer spending patterns, alongside regulatory restrictions on sales and advertising [4] - **Escalated Costs**: Industry participants are affected by cost inflation related to essential materials, energy, and labor, which poses risks to profit margins [5] - **Rising Popularity of Smoke-Free Options**: There is a growing demand for smoke-free alternatives like heated tobacco and vapor products, driven by health awareness and regulatory changes [6] Industry Performance - The Zacks Tobacco industry currently ranks 165, placing it in the bottom 32% of over 243 Zacks industries, indicating dull near-term prospects [7][8] - The industry's consensus estimate for current financial year earnings has decreased by 1.2% since August 2025, reflecting a negative earnings outlook [9] Market Comparison - Over the past year, the Zacks Tobacco industry has outperformed the S&P 500, gaining 36.4% compared to the S&P 500's growth of 18.4% [11] Valuation Metrics - The industry is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 14.44X, lower than the S&P 500's 23.53X and the sector's 16.37X [14] Company Highlights - **Philip Morris International**: This company is transitioning towards a smoke-free future, focusing on reduced-risk products (RRPs) and has seen a 30% increase in shares over the past year [17][19] - **Altria Group**: Altria is prioritizing RRPs and has experienced a 31.7% surge in shares over the past year, supported by its strong legacy brands [22][23] - **Turning Point Brands**: This company has gained momentum with a 105.8% increase in shares over the past year, focusing on innovative product launches and expanding distribution channels [26][28]

Core Insights - Altria offers a high dividend yield of 6.4% and has a strong history of regular dividend increases, making it attractive for income-focused investors [1] - However, the company's core cigarette business is facing significant challenges, including a long-term decline in smoking rates and a 10.2% year-over-year volume drop in Q2 2025 [4][5] - Altria's attempts to offset declining volumes through price increases are becoming less effective, with a 2.5% year-over-year revenue decline from smokeable products in Q2 2025 when excluding tobacco taxes [5] Company Overview - Altria primarily produces tobacco products, with cigarettes being its largest segment, alongside cigars, chewing tobacco, nicotine pouches, and vaping products [2] - The company is categorized as a "sin stock" due to the addictive nature of its products, which fosters customer loyalty similar to other consumer staples [3] Business Challenges - The long-term trend away from smoking poses a significant headwind for Altria, and its efforts to find new growth avenues have not yielded positive results, such as investments in Juul and Cronos leading to large write-offs [5][6] - Altria's decision to spin off Philip Morris International has created a new competitor in the U.S. market, as Philip Morris now sells non-cigarette nicotine products domestically [7] - Recent investments, such as the acquisition of NJOY, have also faced setbacks, including legal issues that hindered product sales [8] Investment Considerations - Despite the attractive dividend yield, the risks associated with Altria's business performance and strategic missteps may deter conservative dividend investors [9] - The company's future outlook appears uncertain, and the perceived safety of its dividend yield may be misleading [10]

Core Insights - Altria Group, Inc. is focusing on a smoke-free future, with its on! nicotine pouches driving significant growth in the oral tobacco products segment, achieving a retail share of 8.7% in the U.S. [1][8] - The company reported a 26.5% increase in shipment volume, reaching 52.1 million cans in the second quarter of 2025, contributing to substantial profit growth [2][8] - Altria's strategy, executed through its subsidiary Helix, emphasizes aggressive brand-building and emotional connections with adult consumers to maintain momentum in a competitive market [3][4] Market Position and Competition - Philip Morris International Inc. is also advancing in the smoke-free product space, with these products accounting for 41% of total net revenues and over 42% of gross profit in the second quarter of 2025, showing 11.8% shipment growth [5] - Turning Point Brands, Inc. is emerging as a competitor, with its Modern Oral sales increasing nearly eightfold year-over-year to $30.1 million, representing 26% of total revenues [6] Financial Performance - Altria's shares have increased by 15.4% over the past three months, contrasting with a 4.3% decline in the industry [7] - The company trades at a forward price-to-earnings ratio of 12.05X, lower than the industry average of 14.27X [10] - Zacks Consensus Estimate indicates year-over-year earnings growth of 6.1% for 2025 and 2.6% for 2026 [11]

Core Viewpoint - Altria Group has a long history of paying and increasing dividends, but its current business fundamentals raise concerns about the sustainability of these dividends in the long term [5][11]. Dividend Information - Altria's board increased the quarterly dividend to $1.06 per share from $1.02, resulting in an annual dividend of $4.24 per share [3]. - To achieve $10,000 in annual dividends, an investor would need approximately 2,360 shares, costing nearly $157,000 based on the closing price of $66.29 [3][4]. Historical Performance - Altria has raised its dividends for 56 consecutive years, placing it in the category of Dividend Kings, which includes companies that have increased dividends for at least 50 years [5]. - The current dividend yield for Altria is 6.4%, significantly higher than the S&P 500 index's yield of 1.2% [6]. Financial Health - Altria's payout ratio stands at 79%, indicating that the company can afford its current dividend payouts in the short term [7]. - The smokeable products division, which generates the majority of revenue, saw a 0.4% year-over-year decline in revenue to $4.6 billion, accounting for 86% of total revenue [8]. - The oral tobacco products division experienced a 6% revenue increase to $728 million, but this was driven by price increases rather than volume growth, which dropped by 1% [9][10]. Market Position and Future Outlook - Altria's total revenue for the second quarter was essentially flat, with a 0.2% increase attributed to higher prices rather than increased demand [10]. - The company is facing challenges with declining volumes and market share, which raises concerns about long-term revenue growth and sustainability of dividends [8][11].

Core Viewpoint - Altria Group Inc. has provided a relatively unusual benefit for high-yield stocks this year [1] Summary by Relevant Categories - Company Performance - Altria Group Inc. has been noted for offering a unique advantage in the high-yield stock sector this year [1]

Core Viewpoint - Altria Group's collaboration with South Korean tobacco giant KT&G could enhance its smoke-free product offerings and secure its high dividend yield for the future [3][6][9] Financial Performance - Altria is a Dividend King with over 50 consecutive years of dividend growth and currently has a forward yield of 6.45% [1] - In Q2 2025, Altria's net revenue fell by 3.6% year-over-year, and GAAP earnings per share decreased by 36.2% [4] - Despite a recent increase in sales of its On! tobacco pouch product, volumes remain significantly lower than market leader Zyn, with On! reporting 52.1 million cans shipped compared to Zyn's 190.2 million cans [5] Strategic Developments - Altria announced a memorandum of understanding for a non-binding global collaboration with KT&G, focusing on the development of non-tobacco nicotine pouches and acquiring an equity stake in Another Snus Factory Stockholm AB [6][7] - The partnership may allow Altria to expand the On! brand globally and explore international growth opportunities for the Loop brand [8] Market Position and Valuation - Altria's potential for growth in non-U.S. markets and modest market share gains in the U.S. nicotine pouch market could stabilize net sales and support modest earnings and dividend growth [9] - Currently, Altria's shares trade at 11.7 times forward earnings, while Philip Morris International trades at nearly 20 times forward earnings, indicating a potential for valuation catch-up [9][10]

Core Viewpoint - The article discusses the current stock market outlook and highlights 11 best and cheap stocks to buy, emphasizing the importance of earnings and interest rates in driving stock prices [2][4][8]. Market Outlook - Jeremy Siegel, a Wharton professor, believes the upward trend in the stock market will continue despite concerns about a government shutdown, as long as it does not last longer than two weeks [2]. - Siegel anticipates that the impact of tariffs will be more evident in the fourth quarter, particularly during the holiday retail season, and expects the Federal Reserve to cut interest rates by 0.25% in October and December [3][4]. Company Insights - **Sanofi (NASDAQ:SNY)**: - Forward P/E Ratio: 9.91, with 24 hedge fund holders [9]. - Recently announced a $625 million investment in Sanofi Ventures, increasing total assets to over $1.4 billion, focusing on biotech and digital health startups [10][11]. - Sanofi is a global healthcare company involved in researching, developing, and marketing medicines and vaccines [12]. - **Altria Group, Inc. (NYSE:MO)**: - Forward P/E Ratio: 12.07, with 54 hedge fund holders [13]. - Received a Buy rating from Bank of America Securities with a price target of $72, highlighting its partnership with KT&G Corp to enhance growth in the oral nicotine market [14][15]. - Altria is a leading American tobacco company providing a range of tobacco products for adult consumers [15].

Core Insights - Altria Group Inc. (NYSE: MO) shares experienced a decline of 1.47% over the past month following a previous gain of 7.36% in the month prior [1] Summary by Category - **Stock Performance** - The stock lost 1.47% in the last month [1] - Prior to this decline, the stock had gained 7.36% [1]

Core Viewpoint - Altria Group's stock has increased by 25% this year, currently trading near all-time highs, while maintaining a high dividend yield of 6.27% [1][2][11] Dividend Yield and Growth - Altria Group has a strong history of dividend growth, with 60 increases in the last 56 years, making it one of the top dividend stocks historically [4] - The dividend yield has decreased from nearly 8% earlier this year to 6.27%, but it remains significantly higher than the S&P 500 average of just over 1% [4] - Over the past decade, Altria's dividend growth has been approximately 87%, contributing to long-term gains for shareholders [5][10] Sustainable Cash Flows - Despite a decline in cigarette usage in the U.S., Altria has managed to grow earnings through consistent price increases, with operating earnings up 4.4% year over year last quarter [6] - Altria is diversifying its product offerings into electronic vaping and nicotine pouches, which are expected to drive long-term growth and counteract declines in cigarette volumes [7] - The company's dividend per share payout over the last 12 months is $4.24, while free cash flow per share is around $5.15, indicating a sustainable capacity for dividend increases [8] Future Outlook - With ongoing price increases, diversification efforts, and a favorable gap between free cash flow and dividend payouts, Altria is positioned to continue its dividend growth over the next decade [10] - A starting dividend yield of 6.27% could potentially yield over 10% on cost basis for shareholders in 10 years, providing consistent income [10]